CAUSEY CHRISTOPHER bought UTHR
July 24, 2025 · Form 4 insider transaction
CAUSEY CHRISTOPHER bought 3,650 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,650
Price
$0.00
Total value
N/A
InsiderCAUSEY CHRISTOPHER
RoleDirector
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateJuly 24, 2025
Filing dateJuly 28, 2025
Shares owned after3,650
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Annual non-employee director award.